STEP 1 Trial — Semaglutide Weight Loss

Source: New England Journal of Medicine (2021).

Key finding: 15.3% mean weight loss at 68 weeks.

Part of GLP1Score's 20-study clinical evidence library — the peer-reviewed research powering our GLP-1 eligibility scoring engine.

Related Reading

Semaglutide in India — Complete Guide
Semaglutide Drug Monograph (dosing, contraindications)
Who Qualifies for Semaglutide in India
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)
Higher-Dose Semaglutide (Up to 16 mg) for Type 2 Diabetes: A Phase 2 Dose-Ranging Study
Effects of Semaglutide on Cardiac Structure and Function in HFpEF with Obesity

Take the Free Eligibility Assessment → · Compare All 18+ Brands